image
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
$ 130.4
-7.47 %
$ 7.33 B
Market Cap
-310.48
P/E
INCOME STATEMENT
634 M REVENUE
0.33%
-35.1 M OPERATING INCOME
-73.61%
-25.5 M NET INCOME
-61.37%
EFFICIENCY
Earnings Waterfall Repligen Corporation
image
Revenue 634 M
Cost Of Revenue 360 M
Gross Profit 275 M
Operating Expenses 310 M
Operating Income -35.1 M
Other Expenses -9.6 M
Net Income -25.5 M
700m700m600m600m500m500m400m400m300m300m200m200m100m100m00(100m)(100m)634m(360m)275m(310m)(35m)10m(26m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Mar-2011 Mar-2010 Mar-2009 Mar-2008 Mar-2007 Mar-2006 Mar-2005 Mar-2004 Mar-2003 Mar-2002 Mar-2001 Mar-2000 Mar-1999 Mar-1998 Mar-1997 Mar-1996 Mar-1995 Mar-1994 Mar-1993 Mar-1992 Mar-1991 Mar-1990 Mar-1989 Mar-1988 Mar-1987 Mar-1986
REVENUE
Revenue 634.4 632.4 801.5 670.5 366.3 270.2 194.0 141.2 104.5 83.5 63.5 68.2 62.3 27.3 21.0 29.4 19.3 14.1 12.9 9.4 6.9 7.8 4.3 2.3 3.5 2.6 2.4 3.8 10.9 16.9 26.8 27.3 11.7 7.6 12.7 8.5 10.2 3.7 3.6
GROSS PROFIT
Cost Of Revenue 359.8 323.5 345.8 279.3 156.6 119.1 86.0 67.0 47.1 35.3 28.0 25.2 27.2 7.1 5.5 6.8 6.2 3.6 3.6 3.9 3.2 3.5 2.0 1.1 0.8 0.4 0.3 0.3 100 K (1.1) 1.5 (0.5) (0.2) (0.6) 10.5 7.6 7.2 4.4 2.6
Gross Profit 274.6 308.8 455.7 391.3 209.6 151.1 108.1 74.2 57.4 48.3 35.5 43.0 35.1 20.2 15.5 22.6 13.1 10.5 9.4 5.5 3.7 4.3 2.3 1.2 2.7 2.2 2.1 3.5 10.8 18.0 25.3 27.8 11.9 8.2 2.2 0.9 3.0 (0.7) 1.0
OPERATING INCOME
Operating Expenses 309.8 261.1 259.8 218.1 139.8 115.1 82.1 60.2 38.2 30.4 22.8 20.0 23.7 20.5 21.2 18.7 (22.8) 12.3 10.6 9.6 13.6 9.4 7.9 8.6 6.6 3.7 2.9 4.0 18.6 38.3 44.5 39.1 24.7 16.5 4.7 4.3 4.1 4.2 3.5
Selling, General and Administrative Expenses 263.4 216.9 215.8 183.9 119.6 95.6 66.3 51.5 30.9 24.7 17.2 12.7 13.2 8.0 7.1 5.9 10.2 6.4 5.4 4.6 4.7 4.2 2.5 2.5 2.5 1.6 1.3 2.4 4.9 4.7 42.1 37.4 23.6 15.6 3.9 3.7 3.6 3.6 3.0
Research and Development Expenses 43.2 42.7 43.9 34.3 20.2 19.4 15.8 8.7 7.4 5.7 5.6 7.3 10.5 12.5 14.2 12.8 7.2 5.9 5.2 5.0 6.5 5.2 5.4 5.8 3.8 1.8 1.4 1.4 12.3 31.0 0 0 0 0 0 0 0 0 0
Operating Income (35.1) 47.7 133.6 133.5 42.5 14.9 26.0 14.0 16.0 13.8 10.7 22.9 11.1 (0.4) (5.8) 3.9 35.9 (1.8) (1.2) (4.2) (9.9) (5.1) (5.6) (7.3) (3.9) (1.5) (0.8) (0.5) (7.8) (20.3) (19.2) (11.3) (12.8) (8.3) (2.5) (3.4) (1.1) (4.9) (2.5)
PRE-TAX INCOME
Interest Income Expense 22.6 10.0 1.2 12.7 12.1 9.3 6.7 6.4 3.8 32 K 50 K 49.8 K 56.7 K 26.2 K 1.97 K 2.96 K 2.96 K 0 0.7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.3 0 0
Total Other Income 8.1 9.0 (5.5) (13.7) (10.6) (9.9) (4.6) (6.8) (4.3) (0.3) 0.4 0.1 (0.1) (2.3) 5.7 0.9 1.9 39.8 0.9 1.9 1 177.8 5.4 1.1 2.1 3.5 1.9 2.0 0.3 0.5 7.8 0.8 7.9 0 7.1 5.9 2.5 3.7 1.1 3.5
Pre-Tax Income (27.0) 56.7 219.1 153.5 59.2 26.2 21.4 7.2 11.7 13.4 11.1 23.0 11.3 43.5 K (4.9) 5.8 37.9 (0.9) 0.7 (3.0) (9.6) (4.5) (4.5) (5.3) (3.8) (2.5) (0.8) (0.5) (11.5) (32.0) (19.5) (11.3) (12.8) (5.7) (2.4) (3.3) 0.3 (20.7) (1.4)
NET INCOME
Tax Provision (1.5) 21.1 33.2 25.3 (0.7) 4.7 4.8 (21.1) 11 K 4.1 3.0 6.9 (2.9) (0.3) (0.8) 26.7 K 0.8 0.9 (0.7) 3.0 9.6 4.5 4.5 5.3 3.8 2.5 0.8 0.5 11.5 32.0 19.5 11.3 12.8 5.7 2.4 3.3 (0.3) 20.7 1.4
Net Income (25.5) 35.6 186.0 128.3 59.9 21.4 16.6 28.4 11.7 9.3 8.2 16.1 14.2 43.5 K (4.1) 5.7 37.1 (0.9) 0.7 (3.0) (9.6) (4.5) (4.5) (5.3) (3.8) (2.5) (0.8) (0.5) (11.5) (32.0) (19.5) (11.3) (12.8) (5.7) (2.4) (3.3) 0.3 (20.7) (1.4)
EPS 0.46 0.64 3.35 2.33 1.14 0.44 0.38 0.74 0.35 0.28 0.25 0.51 0.46 0.0014 0.13 0.19 1.2 0.0293 0.0231 0.0992 0.32 0.17 0.17 0.2 0.18 0.14 0.0485 0.03 0.75 2.08 1.53 0.93 1.14 0.63 0.31 0.46 0.0411 3.59 0.47